Toggle navigation
Home
Search
Services
Blog
Contact
About
Cytokine Regulation of Megakaryocytopoiesis
Murphy, Martin J.
Hipple Cancer Research Corporation, Dayton, OH, United States
Search 58 grants from Martin Murphy
Search grants from Hipple Cancer Research Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
TB detection in children using a novel stool-based GeneXpert assay
Predicting Fetal Acidemia with Intrapartum Electronic Fetal Heart Rate Monitoring
The Healing of the Canoe
Development of Striatal Compartmentalization
NSF East Asia Summer Institutes for US Graduate Students
Recently added grants:
DAMPs, vasa recta pericytes, pressure-natriuresis and hypertension
Angiogenic growth factor delivery for vascular regeneration in critical limb ischemia using acoustically-responsive scaffolds
X-Linked Inhibitor of Apoptosis in Fibroblast Phenotypes and Lung Fibrosis
Mechanical Regulation of Gene Expression in Ventricular Myocytes
Metabolic control of cellular differentiation and the fibrotic response
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44AI032835-03
Application #
2067721
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1992-08-15
Project End
1996-04-30
Budget Start
1995-05-01
Budget End
1996-04-30
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Institution
Name
Hipple Cancer Research Corporation
Department
Type
DUNS #
City
Dayton
State
OH
Country
United States
Zip Code
45439
Related projects
NIH 1995
R44 AI
Cytokine Regulation of Megakaryocytopoiesis
Murphy, Martin J. / Hipple Cancer Research Corporation
NIH 1994
R44 AI
Cytokine Regulation of Megakaryocytopoiesis
Murphy, Martin J. / Hipple Cancer Research Corporation
Comments
Be the first to comment on Martin Murphy's grant